NON-SMALL CELL LUNG CANCER STAGE IIIA

NON-SMALL CELL LUNG CANCER STAGE IIIA was reported 28 times

NON-SMALL CELL LUNG CANCER STAGE IIIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Sphingosine 1-phosphate Receptor Modulator [EPC] 1 0.0001
2 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
3 Integrin Receptor Antagonist [EPC] 2 0.0000
4 Protease Inhibitor [EPC] 1 0.0000
5 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2 0.0000
6 Folate Analog [EPC] 1 0.0000
7 Vitamin A [EPC] 1 0.0000
8 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
9 Nicotinic Acid [EPC] 1 0.0000
10 Antidote [EPC] 1 0.0000
11 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
12 Microtubule Inhibitor [EPC] 2 0.0000
13 Platinum-based Drug [EPC] 3 0.0000
14 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
15 Antiarrhythmic [EPC] 1 0.0000
16 Kinase Inhibitor [EPC] 5 0.0000
17 Parathyroid Hormone Analog [EPC] 1 0.0000
18 Aromatase Inhibitor [EPC] 1 0.0000
19 Fluoroquinolone Antibacterial [EPC] 1 0.0000
20 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
21 Aldosterone Antagonist [EPC] 1 0.0000
22 Janus Kinase Inhibitor [EPC] 1 0.0000
23 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
24 Interferon beta [EPC] 1 0.0000
25 Vitamin D [EPC] 1 0.0000
26 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
27 Vitamin B12 [EPC] 1 0.0000
28 Vitamin C [EPC] 1 0.0000
29 Insulin Analog [EPC] 1 0.0000
30 Atypical Antipsychotic [EPC] 1 0.0000
31 Loop Diuretic [EPC] 1 0.0000
32 Thalidomide Analog [EPC] 1 0.0000
33 Platelet Aggregation Inhibitor [EPC] 1 0.0000
34 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
35 Corticosteroid [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000